J Liver Cancer.  2016 Sep;16(2):82-85. 10.17998/jlc.2016.16.2.82.

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis

Affiliations
  • 1Department of Internal Medicine, Korea Cancer Center Hospital, Korean Institute of Radiological and Medical Sciences, Seoul, Korea. hepapark@kcch.re.kr

Abstract

Transarterial chemoembolization (TACE) has been widely performed as a treatment for unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC is increasing due to improvement of survival. Sorafenib has been generally accepted as a standard treatment in advanced HCC. However, many HCC patients with EHM are treated with TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for the patients with HCC and EHM will be discussed.

Keyword

Hepatocellular carcinoma; Extrahepatic metastasis; Transarterial chemoembolization
Full Text Links
  • JLC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr